Showing 1 - 4 of 4
SUBJECT AREAS: Biotechnology, Decision trees, Equity financing, Ramp;D, ValuationCASE SETTINGS: Sunnyvale, CA; Pharmaceutical industry; $1.3 million revenues; 2000Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for...
Persistent link: https://www.econbiz.de/10012754464
Research in behavioral corporate finance takes two distinct approaches. The first emphasizes that investors are less than fully rational. It views managerial financing and investment decisions as rational responses to securities market mispricing. The second approach emphasizes that managers are...
Persistent link: https://www.econbiz.de/10012762557
Research in behavioral corporate finance takes two distinct approaches. The first emphasizes that investors are less than fully rational. It views managerial financing and investment decisions as rational responses to securities market mispricing. The second approach emphasizes that managers are...
Persistent link: https://www.econbiz.de/10012765920
Research in behavioral corporate finance takes two distinct approaches. The first emphasizes that investors are less than fully rational. It views managerial financing and investment decisions as rational responses to securities market mispricing. The second approach emphasizes that managers are...
Persistent link: https://www.econbiz.de/10012727672